These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21679146)

  • 1. Cytomegalovirus infections in non-immunocompromised and immunocompromised patients in the intensive care unit.
    Florescu DF; Kalil AC
    Infect Disord Drug Targets; 2011 Aug; 11(4):354-64. PubMed ID: 21679146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of letermovir: a cytomegalovirus prophylactic option.
    Gerna G; Lilleri D; Baldanti F
    Expert Opin Pharmacother; 2019 Aug; 20(12):1429-1438. PubMed ID: 31282759
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.
    Hebart H; Kanz L; Jahn G; Einsele H
    Drugs; 1998 Jan; 55(1):59-72. PubMed ID: 9463790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral treatment of cytomegalovirus infection.
    Ahmed A
    Infect Disord Drug Targets; 2011 Oct; 11(5):475-503. PubMed ID: 21827432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.
    Torres-Madriz G; Boucher HW
    Clin Infect Dis; 2008 Sep; 47(5):702-11. PubMed ID: 18652557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
    Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
    New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised.
    Baldanti F; Revello MG; Percivalle E; Gerna G
    J Clin Virol; 1998 Jul; 11(1):51-60. PubMed ID: 9784143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
    Limaye AP
    Semin Respir Infect; 2002 Dec; 17(4):265-73. PubMed ID: 12497543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small bowel transplantation complicated by cytomegalovirus tissue invasive disease without viremia.
    Avsar Y; Cicinnati VR; Kabar I; Wolters H; Anthoni C; Schmidt HH; Beckebaum S
    J Clin Virol; 2014 Jun; 60(2):177-80. PubMed ID: 24703746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of cytomegalovirus infection in organ transplant recipients.
    Kusne S; Shapiro R; Fung J
    Transpl Infect Dis; 1999 Sep; 1(3):187-203. PubMed ID: 11428989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistant Cytomegalovirus Infection in Solid-organ Transplantation: Single-center Experience, Literature Review of Risk Factors, and Proposed Preventive Strategies.
    Majeed A; Latif A; Kapoor V; Sohail A; Florita C; Georgescu A; Zangeneh T
    Transplant Proc; 2018 Dec; 50(10):3756-3762. PubMed ID: 30586840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.
    Young PG; Rubin J; Angarone M; Flaherty J; Penugonda S; Stosor V; Ison MG
    Transpl Infect Dis; 2016 Jun; 18(3):390-5. PubMed ID: 27037651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of cytomegalovirus infection in solid organ transplantation.
    Kotton CN
    Nat Rev Nephrol; 2010 Dec; 6(12):711-21. PubMed ID: 20978468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus.
    Germi R; Mariette C; Alain S; Lupo J; Thiebaut A; Brion JP; Epaulard O; Saint Raymond C; Malvezzi P; Morand P
    Antiviral Res; 2014 Jan; 101():57-61. PubMed ID: 24184983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Developments in the Management of Cytomegalovirus Infection After Transplantation.
    Meesing A; Razonable RR
    Drugs; 2018 Jul; 78(11):1085-1103. PubMed ID: 29961185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection.
    Avery RK; Arav-Boger R; Marr KA; Kraus E; Shoham S; Lees L; Trollinger B; Shah P; Ambinder R; Neofytos D; Ostrander D; Forman M; Valsamakis A
    Transplantation; 2016 Oct; 100(10):e74-80. PubMed ID: 27495775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts.
    Reusser P
    Expert Opin Investig Drugs; 2001 Sep; 10(9):1745-53. PubMed ID: 11772283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients.
    Razonable RR
    Infect Dis Clin North Am; 2013 Jun; 27(2):317-42. PubMed ID: 23714343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.